- 全部删除
您的购物车当前为空
GSK2324 是一种有效的 FXR 激动剂,通过减少脂肪酸合成的吸收和选择性减少来控制肝脂质,可用于治疗非酒精性脂肪肝。


为众多的药物研发团队赋能,
让新药发现更简单!
GSK2324 是一种有效的 FXR 激动剂,通过减少脂肪酸合成的吸收和选择性减少来控制肝脂质,可用于治疗非酒精性脂肪肝。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 2,360 | In stock | |
| 5 mg | ¥ 5,690 | In stock | |
| 10 mg | ¥ 7,930 | In stock | |
| 25 mg | ¥ 11,800 | In stock | |
| 50 mg | ¥ 15,900 | In stock | |
| 100 mg | ¥ 21,300 | In stock |
GSK2324 相关产品
| 产品描述 | GSK2324 is a potent FXR agonist for the treatment of NAFLD by controlling hepatic lipids through reduced uptake and selective reduction of fatty acid synthesis. |
| 别名 | GSK-2324, GSK 2324 |
| 分子量 | 533.4 |
| 分子式 | C29H22Cl2N2O4 |
| CAS No. | 1020567-30-9 |
| Smiles | C(OC1=CC=C(C=C1)C2=CC3=C(C=C2)N=C(C(O)=O)C=C3)C=4C(=NOC4C(C)C)C5=C(Cl)C=CC=C5Cl |
| 密度 | 1.351 g/cm3 (Predicted) |
| 存储 | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 100 mg/mL (187.48 mM), Sonication is recommended. H2O: < 1 mg/mL (insoluble or slightly soluble) | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容